Analysis of large datasets for identifying molecular targets in intestinal polyps and metabolic disorders
S.-H.I. Ou(Chongqing Medical and Pharmaceutical College), JIE YAO(Chongqing Medical and Pharmaceutical College)
Cited by 5
Related Papers
MA07.04 Amivantamab and Lazertinib in Combination with Platinum-Based Chemotherapy in Relapsed/Refractory EGFR-mutant NSCLC
|Journal of Thoracic Oncology|2022|4
MA13.06 Amivantamab, Lazertinib Plus Platinum-based Chemotherapy in EGFR-mutated Advanced NSCLC: Updated Results from CHRYSALIS-2
|Journal of Thoracic Oncology|2023|4